Shares in Xeris Pharmaceuticals are rising 9% in Wednesday’s pre-market session after the company announced that the US Food and Drug Administration (FDA) granted Fast Track designation for its XP-0863
Shares in Xeris Pharmaceuticals are rising 9% in Wednesday’s pre-market session after the company announced that the US Food and Drug Administration (FDA) granted Fast Track designation for its XP-0863
Xeris Pharmaceuticals (XERS) spiked 12% in Friday’s after-hours trading after a filing disclosed that Soros Fund Management, LLC holds a 5.3% stake in the company with ~2.5M common shares. Soros
